Eloxx Pharmaceuticals, Inc.
Clinical trials sponsored by Eloxx Pharmaceuticals, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug aims to slow kidney damage in rare alport syndrome Results expected Jun 2027 (estimated)